VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo
| Image |  |
|---|---|
| Description | scientific article published on 02 November 2020 |
| Author/s |
author: Yan Xu Bharat K R Chaganty Kenneth C. Anderson Yu-Tzu Tai |
| Publication date | November 2, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |